Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxolone in Unipolar Depression
NCT05570110Phase 2Recruiting
- Sponsor
- Philipps-Universität Marburg
- Start
- Sep 2022
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of glycyrrhetinic acid in major depressive disorder (MDD), sponsored by Philipps-Universität Marburg. Started Sep 2022; status: recruiting.
02
Drugs
glycyrrhetinic acid
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05570110.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05570110.